Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...
How GLP-1 medications are transforming diabetes and weight loss treatment
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
MM&M5d
Hims & Hers set for Super Bowl ad debut highlighting GLP-1 weight loss drugs
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Business Wire8d
TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
“The body of evidence for the GLP-1 drug class shows that up to 40% of total weight loss in GLP-1 patients ... which includes both FDA approved drugs and CBD products not currently regulated ...
Philadelphia Tribune9d
GLP-1 medications may have health benefits beyond weight loss and blood sugar control
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...
JD Supra10d
The GLP-1 Saga Continues: FDA Ends the Tirzepatide Shortage: Frequently Asked Questions
Lilly is tirzepatide’s patentholder and the manufacturer of the two branded versions of tirzepatide, Mounjaro® (for diabetes) and Zepbound® (for weight loss ... FDA that these GLP-1 drugs ...